TearLab Corporation Revenue Growth: 58.57%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TEAR Revenue Growth Rankings
| Overall | 92nd percentile | 353 of 4424 |
| Sector | 86th percentile | 61 of 464 in Healthcare |
| Industry | 87th percentile | 3 of 24 in Medical Laboratories & Research |
TEAR Revenue Growth Range, Past 5 Years
| Minimum | -86.55% | Sep 2006 |
| Maximum | -70.27% | Dec 2005 |
| Average |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these TEAR related companies
TEAR News
TearLab (TEAR) Reports Center for Medicare and Medicaid Approves Reconsideration Request
Dec 13, 2:41PM Street Insider
Dec 13, 2:41PM Street Insider
TearLab to Present at the 23rd Annual Piper Jaffray Healthcare Conference
Nov 22, 10:30AM GlobeNewswire
Nov 22, 10:30AM GlobeNewswire
TearLab Corporation to Release Q3 2011 Financial Results on November 10, 2011
Oct 31, 4:30PM GlobeNewswire
Oct 31, 4:30PM GlobeNewswire
Seasoned International Eye Care Industry Professional, Richard Lee, Joins TearLab Team
Sep 07, 2:00PM GlobeNewswire
Sep 07, 2:00PM GlobeNewswire
TearLab to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
Sep 06, 7:30AM GlobeNewswire
Sep 06, 7:30AM GlobeNewswire
TearLab Corporation Launches New Consumer Website and Social Media Program Focused on Dry Eye Disease
Aug 23, 8:30AM GlobeNewswire
Aug 23, 8:30AM GlobeNewswire
$TEAR New U.S. Patent Protects Expansion of Tear Testing Beyond Osmolarity 8:30a ET April 26, 2011 (GlobeNewswire)
about 292 days ago by Isledeclare
about 292 days ago by Isledeclare
$TEAR http://chart.ly/5uwpg44 Gonna keep an eye on this one, really like it over 2.30 w/ volume
about 321 days ago by Tr8r_x
about 321 days ago by Tr8r_x
$TEAR--Insider purchase came through after the close Friday afternoon. Director purchased 39,100 shares at $2.51. Stock closed at $2.67.
about 398 days ago by MicroInsider
about 398 days ago by MicroInsider
More stocks $CNST micro cap up strong on plant closings cost cutting $TEAR big gain on proposed CMS rate $DJSP watching on foreclosure news
about 492 days ago by Detroitblues
about 492 days ago by Detroitblues
$IPCI another one going wild on NO NEWS a mere mortal can find. Frontrunning insiders like $TEAR
about 702 days ago by GoodLuk2You
about 702 days ago by GoodLuk2You
Anyone know anything about the HUGE upside spike in $TEAR ?? I've held this dog for years all of a sudden a big upside. Any information?
about 702 days ago by Jonijam
about 702 days ago by Jonijam
Holding $DKS and $TEAR both stocks performing really well. Products that shine.
about 702 days ago by ShaunRoark
about 702 days ago by ShaunRoark
Bought 2000 shares of $TEAR stop loss at $3.56 sell at $4.31 in long term. Very useful diagnostic tool for LASIK and cataracts.
about 702 days ago by ShaunRoark
about 702 days ago by ShaunRoark
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TEAR | 1.66 | -0.12 | -6.74% | 33.90M |
| CSCO | 19.89 | -0.10 | -0.53% | 106.74B |
| BFLY | 2.13 | -0.00 | -0.12% | 52.36M |
| TSPT | 8.28 | 0.13 | 1.60% | 111.95M |
| OMEX | 3.36 | -0.06 | -1.75% | 244.57M |
| TWER | 2.71 | -0.09 | -3.05% | 144.04M |
| EBAY | 33.02 | -0.23 | -0.71% | 42.63B |
| NCTY | 7.44 | 0.06 | 0.81% | 173.13M |
| MSFT | 30.50 | -0.28 | -0.89% | 256.53B |
| WBMD | 27.09 | -0.51 | -1.85% | 1.59B |
